What is Veradermics 's additional paid-in capital?

Veradermics (MANE) reported additional paid-in capital of $543.04M in Q1 2026.

What does additional paid-in capital mean?

Capital contributed by shareholders above the nominal par value of the stock.

Veradermics Additional Paid-In Capital increased by 23047.7% to $543.04M in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionEquity

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ3 2015

Last reportedQ4 2025

An increase typically signals recent equity financing activities or the issuance of shares for employee compensation.

Additional paid-in capital represents the amount of capital received from investors in excess of the par value of the is...

Common in all corporations; levels depend on the history of equity issuance and stock-based compensation.

Metric ID: additional_paid_in_capital

2 periods

	Q4 '25	Q1 '26
Value	$2.35M	$543.04M
QoQ Change	—	>999%

Range$2.35M – $543.04M

What is Veradermics 's additional paid-in capital?: Veradermics (MANE) reported additional paid-in capital of $543.04M in Q1 2026.
What does additional paid-in capital mean?: Capital contributed by shareholders above the nominal par value of the stock.